# buprenorphine hydrochloride and naloxone hydrochloride dihydrate

NDC: 58118-1189
Generic name: buprenorphine hydrochloride and naloxone hydrochloride dihydrate
Labeler / Manufacturer: Clinical Solutions Wholesale, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: SUBLINGUAL
Marketing started: 20140627

FDA application: ANDA203326

## Active ingredients

- BUPRENORPHINE HYDROCHLORIDE: 8 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58118-1189"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58118-1189
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=99a5b62f-bc08-44f4-abb8-300520d2162a